Nicholson, K G <br/><br/>
Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza.  [electronic resource] 

 -  Lancet (London, England)  Jun 2001 
 - 1937-43 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0140-6736 
<br/><br/><label>Standard No.: </label>10.1016/S0140-6736(00)05066-2  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Animals<br/>Antibody Formation<br/>Ducks--virology<br/>Female<br/>Humans<br/>Immunization, Secondary<br/>Influenza A Virus, H5N1 Subtype<br/>Influenza A virus--immunology<br/>Influenza Vaccines--administration & dosage<br/>Influenza in Birds--immunology<br/>Male<br/>Polysorbates--administration & dosage<br/>Single-Blind Method<br/>Squalene--administration & dosage<br/>Vaccines, Inactivated--administration & dosage